Eiko LifeSciences Limited (ELL), announced that it has acquired a 25.01 per cent stake in Reflux Pharmaceuticals Private Limited (RPPL), a pharmaceutical company that specialises in manufacturing and exporting active...
Pharmaceutical
Spanish pharmaceutical firm Esteve sells 26% stake to Germany’s Lubea
Spanish pharmaceuticals company Esteve has agreed to sell a 26% stake to German private investment firm Lubea, which will become a strategic partner, the family-owned firm based in Barcelona said in a statement on...
Pfizer plans $31 bln debt offering to fund Seagen takeover
Pfizer Inc said it plans to raise $31 billion from a debt offering to finance its proposed acquisition of Seagen Inc. Pfizer struck a $43 billion deal in March to acquire Seagen and its targeted cancer therapies as it...
Sanofi India board OKs demerger of consumer health business
Sanofi India said its board has approved the demerger of consumer health business into its proposed wholly-owned subsidiary Sanofi Consumer Healthcare India (SCHIL), subject to the approval of Sanofi India’s...
Astellas Pharma buys Iveric Bio for $5.9 billion
Japan’s Astellas Pharma said it agreed to buy U.S. drugmaker Iveric Bio Inc for about $5.9 billion in its biggest acquisition, giving it access to a range of ophthalmology treatments. The deal marks the fifth...
China’s Fosun drops plan to sell stake in Indian drugmaker Gland Pharma – ET Now
China’s Shanghai Fosun Pharmaceutical Group Co Ltd has withdrawn plans to sell stake in Indian drugmaker Gland Pharma Ltd, ET Now tweeted on Wednesday, citing sources. Fosun Pharma holds a 57.86% stake in the...
Ipca Labs set to acquire Unichem promoter’s stake for over ₹ 1,034 cr
lpca Laboratories on Monday said it has entered into a definitive share purchase agreement to acquire Unichem Laboratories promoter’s stake for ₹1,034.06 crore in an all cash deal. lpca will acquire 2,35,01,440...
CCI clears Berhyanda’s acquisition of Suven Pharma
The Competition Commission of India (CCI) has approved Berhyanda Ltd’s acquisition of up to 76.10% in Suven Pharmaceuticals. The acquisition is “by way of a share purchase agreement of December 26, 2022 and pursuant to...
NCLT OKs resolution plan worth ₹250 crore for Unimark Remedies
The National Company Law Tribunal in its order approved the resolution plan for Unimark Remedies, which was submitted by a consortium of Asset Reconstruction Company (India), Intas Pharmaceutical and Shamrock...
Bankruptcy court approves Intas-Shamrock plan for Unimark Remedies
A bankruptcy court on Monday allowed the Intas Pharmaceuticals-Shamrock Pharmachemi consortium’s application to acquire Unimark Remedies. Asset Reconstruction Company India Ltd (Arcil) is also part of the consortium...
EQT in talks for a possible $5.80 billion offer for Dechra
Dechra, a British veterinary pharmaceuticals maker, said it had entered into talks with private equity group EQT for a possible offer in a 4.63 billion pounds ($5.80 billion) all-cash deal. Dechra shareholders would...
Glenmark weighs sale of API business to pare debt
Glenmark Pharmaceuticals Ltd is considering selling a majority stake in Glenmark Life Sciences to pare debt, said two people familiar with the development. Kotak Mahindra Capital Co. Ltd has been hired to run the sale...
